Page 28 - Read Online
P. 28

In the present study, both patients were treated at    Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP,
           recurrence with carmustine wafers that were placed     Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM,
           around the resection cavity. Carmustine wafers have    Jhanwar SC, Rosenblum MK, Lassman AB. Recursive partitioning
                                                                  analysis of  prognostic variables in newly diagnosed anaplastic
           been shown to yield better survival rates of 1-2 months   oligodendroglial tumors. Neuro Oncol 2014;16:1541‑6.
           in primary high-grade gliomas. [16]  Thus, the prolonged   7.   Miller JT, Rahimi SY, Lee M. History of infection control and its
           survival of both patients cannot be attributed to the   contributions to the development and success of brain tumor
           implanted wafers.                                  8.   operations. Neurosurg Focus 2005;18:e4.
                                                                  Alexiou GA, Goussia A, Voulgaris S, Fotopoulos AD, Fotakopoulos G,
                                                                  Ntoulia  A,  Zikou  A,  Tsekeris  P,  Argyropoulou  MI,  Kyritsis  AP.
           In conclusion, the role of infection provides a rationale   Prognostic significance of MRP5 immunohistochemical expression
           for further research in cancer treatment. Certainly,   in glioblastoma. Cancer Chemother Pharmacol 2012;69:1387‑91.
           there is a need for larger studies that may provide more   9.   Bohman LE, Gallardo J, Hankinson TC, Waziri AE, Mandigo CE,
                                                                  McKhann GM 2nd, Sisti MB, Canoll P, Bruce JN. The survival impact
           accurate answers. This may also lead to a subgroup     of postoperative infection in patients with glioblastoma multiforme.
           analysis that would better define if patients survival is   Neurosurgery 2009;64:828‑34.
           influenced by bacterial strain, location of the infection   10.  Löhr M, Molcanyi M, Poggenborg J, Spuentrup E, Runge M, Röhn G,
           or time to infection.                                  Hartig W, Hescheler J, Hampl JA. Intracerebral administration of
                                                                  heat‑inactivated Staphylococcus epidermidis enhances oncolysis
                                                                  and prolongs survival in a 9L orthotopic gliosarcoma model. Cell
           REFERENCES                                             Physiol Biochem 2013;31:614‑24.
                                                              11.  Decker WK, Safdar A. Bioimmunoadjuvants for the treatment of
           1.   Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G,   neoplastic and infectious disease: coley’s legacy revisited. Cytokine
              Tsavachidis  S, Liang  FW, Gilbert  M, Aldape  K, Armstrong  T,   Growth Factor Rev 2009;20:271‑81.
              Houlston R, Hosking F, Robertson L, Xiao Y, Wiencke J, Wrensch M,   12.  Tanaka R, Sekiguchi K, Suzuki Y, Sobue H, Ueki K. Preliminary
              Andersson  U,  Melin  BS,  Bondy  M.  Polymorphisms  of  LIG4,   evaluation of intratumoral injection of a Streptococcus pyrogenes
              BTBD2, HMGA2, and RTEL1 genes involved in the double‑strand   preparation  in  patients  with  malignant  brain tumors.  Cancer
              break repair pathway predict glioblastoma survival. J Clin Oncol   1980;46:1688‑94.
              2010;28:2467‑74.                                13.  Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley
           2.   Nuño M, Birch K, Mukherjee D, Sarmiento JM, Black KL, Patil CG.   and tumour regression: a place in history or in the future. Postgrad
              Survival and prognostic factors of anaplastic gliomas. Neurosurgery   Med J 2003;79:672‑80.
              2013;73:458‑65.                                 14.  Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative
           3.   De Bonis P, Albanese A, Lofrese G, de Waure C, Mangiola A,   infection and increased survival in osteosarcoma patients: are they
              Pettorini BL, Pompucci A, Balducci M, Fiorentino A, Lauriola L,   associated? Ann Surg Oncol 2007;14:2887‑95.
              Anile C, Maira G. Postoperative infection may influence survival   15.  Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative
              in patients with glioblastoma: simply a myth?  Neurosurgery   empyema improves survival in lung cancer. Documentation and
              2011;69:864‑8.                                      analysis of a natural experiment. N Engl J Med 1972;287:1013‑7.
           4.   Bowles AP Jr, Perkins  E. Long‑term remission of malignant   16.  Bregy  A, Shah  AH, Diaz  MV, Pierce  HE, Ames  PL, Diaz  D,
              brain tumors after intracranial infection: a report of four cases.   Komotar RJ. The role of Gliadel wafers in the treatment of high‑grade
              Neurosurgery 1999;44:636‑42.                        gliomas. Expert Rev Anticancer Ther 2013;13:1453‑61.
           5.   Cairncross  JG,  Wang  M,  Jenkins  RB,  Shaw  EG,  Giannini  C,
              Brachman DG, Buckner JC, Fink KL, Souhami L, Laperriere NJ,
              Huse JT, Mehta MP, Curran WJ, Jr. Benefit from procarbazine,   Cite this article as: Alexiou GA, Kallinteri A, Michos E, Zagorianakou P,
              lomustine, and vincristine in oligodendroglial tumors is associated   Priavali E, Pachatouridis D, Levidiotou S, Voulgaris S. The influence of
              with mutation of IDH. J Clin Oncol 2014;32:783‑90.  postoperative infection in survival of patients with high-grade gliomas.
           6.   Panageas KS, Reiner AS, Iwamoto FM, Cloughesy TF, Aldape KD,   Neuroimmunol Neuroinflammation 2015;2(1):18-20.
              Rivera  AL, Eichler  AF, Louis  DN, Paleologos  NA, Fisher  BJ,   Source of Support: Nil. Conflict of Interest: No.
              Ashby LS, Cairncross JG, Roldan Urgoiti GB, Wen PY, Ligon KL,   Received: 19-08-2014; Accepted: 01-09-2014






























            20                                             Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015
   23   24   25   26   27   28   29   30   31   32   33